Health apps targeting children with overweight-a protocol for a systematic review with meta-analysis and Trial

Rajeeb Rashid1, Paolo Perego2, Laura Condon3

  • 1Paediatric Unit, Department of Child Health, University of Edinburgh, St John's Hospital, Livingston, EH54 6PP, UK.

Systematic Reviews
|February 13, 2020
PubMed

Insights

This systematic review examines smartphone apps for overweight children. It aims to determine the clinical effects of these mHealth apps on body mass index (BMI) and overall health outcomes.

Area of Science:

  • Pediatrics
  • Public Health
  • Digital Health

Background:

  • Childhood overweight is a growing global health concern.
  • Multi-component interventions (diet, physical activity, behavior change) can reduce body mass index (BMI).
  • The clinical impact of smartphone applications (apps) for managing childhood overweight remains largely unknown.

Purpose of the Study:

  • To systematically review the effects of mHealth apps on children with overweight.
  • To evaluate the efficacy and safety of smartphone applications as an intervention tool for pediatric overweight.
  • To identify evidence gaps for future mHealth interventions in children.

Main Methods:

  • Systematic review of randomized clinical trials (RCTs) involving children aged 0-18 years with overweight.
  • Comparison of mHealth apps against sham apps, no app, or usual care.
  • Comprehensive database searches (Cochrane Library, Embase, PsycINFO, PubMed, IEEE, Web of Science, CINAHL, LILACS).
  • Assessment of primary outcomes (body weight, quality of life, serious adverse events) and secondary outcomes (self-efficacy, anxiety, depression).
  • Independent data extraction and bias risk assessment by at least two authors.
  • Risk of bias evaluation using eight domains and Trial Sequential Analysis for random errors.
  • Quality of evidence assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) tool.

Main Results:

  • This section will present the synthesized evidence on the beneficial and harmful effects of mHealth apps for children with overweight, based on the included RCTs.
  • The review will highlight the impact on primary outcomes such as body weight and quality of life, as well as secondary outcomes like self-efficacy and mental health indicators.
  • Potential biases towards benefits due to the inclusion of only RCTs will be acknowledged.

Conclusions:

  • The systematic review will provide evidence regarding the effectiveness and safety of smartphone applications for pediatric overweight management.
  • Findings will inform the development of future mHealth interventions by identifying successful strategies and areas needing further research.
  • The study aims to contribute to the understanding of digital health tools in addressing the rising prevalence of childhood overweight.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
166
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146